Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

In a challenging turn of events for Ocean Biomedical, the company's stock has tumbled to a 52-week low, reaching a price ...

Lifecore Biomedical, Inc. announced plans to hold a special stockholders meeting on April 10, 2025, to seek approval for a proposal related to its Series A Convertible Preferred Stock. The ...

Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its product platform is ...

Lifecore’s board of directors has approved that holders of record of Lifecore’s Common Stock and Convertible Preferred Stock as of the close of business on February 18, 2025 (the “Record Date”), will ...

WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and ...

Clearside Biomedical (CLSD) announced that Arctic Vision’s new drug applications for ARCATUS have been approved by the Therapeutic Goods ...

CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing ...